Combined bottle and lens case
- Allergan
Latest Allergan Patents:
- Conformationally rigid bicyclic and adamantane derivatives useful as &agr;2-adrenergic blocking agents
- ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO [1,2-G]CHROM-3-ENE, BENZO[1,2-G]-THIOCHROM-3-ENE AND BENZO [1,2-G]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
- Multi-purpose contact lens care compositions
- Primary and supplemental intraocular lens system
- Method and compositions for the treatment of cerebral palsy
Description
FIG. 1 is a front elevaitonal view of a combined bottle and lens case showing our new design; the rear being identical;
FIG. 2 is a side elevational view thereof both sides being identical;
FIG. 3 is a bottom plan view thereof; and,
FIG. 4 is a top plan view thereof.
Referenced Cited
Patent History
Patent number: D404915
Type: Grant
Filed: Apr 21, 1997
Date of Patent: Feb 2, 1999
Assignee: Allergan (Waco, TX)
Inventors: Joseph M. Kornick (Chicago, IL), J. Tirso Olivares (Chicago, IL)
Primary Examiner: Celia Murphy
Attorney: Carlos A. Fisher
Application Number: 0/69,493
Type: Grant
Filed: Apr 21, 1997
Date of Patent: Feb 2, 1999
Assignee: Allergan (Waco, TX)
Inventors: Joseph M. Kornick (Chicago, IL), J. Tirso Olivares (Chicago, IL)
Primary Examiner: Celia Murphy
Attorney: Carlos A. Fisher
Application Number: 0/69,493
Classifications
Current U.S. Class:
D/3264;
D3/263;
D9/337;
D9/520
International Classification: 0301;
International Classification: 0301;
